FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1570656633> ?p ?o ?g. }

• W1570656633 endingPage "2" @default.
• W1570656633 startingPage "1" @default.
• W1570656633 abstract "Recent data suggests that valproic acid (VPCA) also attenuates and limits tumor growth in a number of systemic malignancies [1].For instance, VPCA has a suppressive effect on tumor growth in renal malignancies. Oertl et al. have recently shown that VPCA mediates this role in part by altering the expression of beta1 integrins in tumor cells [2]. VPCA also mediates this role in part by upregulating BAX expression. These changes have recently been confirmed in Caki-1 and KTC-26 cell lines. In addition, VPCA accentuates the expression of ULBP1 and ULBP2. Jones et al. have recently demonstrated that, at the same time, VPCA accentuates p21 expression [3]. Recent data also suggests that IFN-alpha accentuates the cytotoxic effects of VPCA. Cyclin B and cyclin D3 levels are also modulated by VPCA [4]. Yang et al. have recently demonstrated that VPCA also accentuates the cytotoxicity of NK cells against renal cancer cells [5]. In addition, VPCA also affects tumor cell adhesiveness thereby further attenuating tumor expansion in renal carcinomas [6].Similarly, VPCA has an inhibitory effect on tumor growth in gastric malignancies. VPCA has a positive impact on acetyl-α-tubulin levels. It also mediates this role in part by attenuating c-Myc expression. Bcl-2 expression is downregulated concurrently. As a result, tumor cell apoptosis is markedly augmented. Zhao et al. have recently demonstrated that this is accompanied by accentuation of p21 (Waf/cip1) expression [7]. These changes have recently been confirmed in BGC-823, OCUM-2MD3, HGC-27, and SGC-7901 cell lines. In addition, VPCA has a negative impact on cyclin A as well as cyclin D1 expression. At the same time, tumor cell proliferation is markedly attenuated [8]. This is accompanied by accentuation of acetyl-histone H3 levels. G1 phase arrest is typically seen. In addition, Yagi et al. have recently demonstrated that survivin expression is significantly downregulated [9]. Mad1 expression is upregulated concurrently. p27 expression is also accentuated simultaneously. Besides the above-mentioned changes, VPCA also augments and enhances caspase 9 and caspase 3 activation thereby further abrogating tumor growth in gastric carcinomas.As is obvious from the above discussion, VPCA exhibits potent tumor growth mitigating effects. Hopefully, the coming few years will see an increase in the utilization of VPCA as an antineoplastic agent." @default.
• W1570656633 created "2016-06-24" @default.
• W1570656633 creator A5068544138 @default.
• W1570656633 date "2015-01-01" @default.
• W1570656633 modified "2023-09-23" @default.
• W1570656633 title "Tumor Growth Mitigating Effects of Valproic Acid in Systemic Malignancies" @default.
• W1570656633 cites W1967576122 @default.
• W1570656633 cites W1974938521 @default.
• W1570656633 cites W1988795806 @default.
• W1570656633 cites W2018902367 @default.
• W1570656633 cites W2027715898 @default.
• W1570656633 cites W2057366527 @default.
• W1570656633 cites W2077699195 @default.
• W1570656633 cites W2080049682 @default.
• W1570656633 cites W2129304314 @default.
• W1570656633 doi "https://doi.org/10.1155/2015/540183" @default.
• W1570656633 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4531201" @default.
• W1570656633 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26290769" @default.
• W1570656633 hasPublicationYear "2015" @default.
• W1570656633 type Work @default.
• W1570656633 sameAs 1570656633 @default.
• W1570656633 citedByCount "1" @default.
• W1570656633 countsByYear W15706566332016 @default.
• W1570656633 crossrefType "journal-article" @default.
• W1570656633 hasAuthorship W1570656633A5068544138 @default.
• W1570656633 hasBestOaLocation W15706566331 @default.
• W1570656633 hasConcept C109316439 @default.
• W1570656633 hasConcept C118552586 @default.
• W1570656633 hasConcept C121608353 @default.
• W1570656633 hasConcept C126322002 @default.
• W1570656633 hasConcept C154317977 @default.
• W1570656633 hasConcept C190283241 @default.
• W1570656633 hasConcept C202751555 @default.
• W1570656633 hasConcept C2777172819 @default.
• W1570656633 hasConcept C2778186239 @default.
• W1570656633 hasConcept C502942594 @default.
• W1570656633 hasConcept C54355233 @default.
• W1570656633 hasConcept C55493867 @default.
• W1570656633 hasConcept C62112901 @default.
• W1570656633 hasConcept C71924100 @default.
• W1570656633 hasConcept C81885089 @default.
• W1570656633 hasConcept C86803240 @default.
• W1570656633 hasConceptScore W1570656633C109316439 @default.
• W1570656633 hasConceptScore W1570656633C118552586 @default.
• W1570656633 hasConceptScore W1570656633C121608353 @default.
• W1570656633 hasConceptScore W1570656633C126322002 @default.
• W1570656633 hasConceptScore W1570656633C154317977 @default.
• W1570656633 hasConceptScore W1570656633C190283241 @default.
• W1570656633 hasConceptScore W1570656633C202751555 @default.
• W1570656633 hasConceptScore W1570656633C2777172819 @default.
• W1570656633 hasConceptScore W1570656633C2778186239 @default.
• W1570656633 hasConceptScore W1570656633C502942594 @default.
• W1570656633 hasConceptScore W1570656633C54355233 @default.
• W1570656633 hasConceptScore W1570656633C55493867 @default.
• W1570656633 hasConceptScore W1570656633C62112901 @default.
• W1570656633 hasConceptScore W1570656633C71924100 @default.
• W1570656633 hasConceptScore W1570656633C81885089 @default.
• W1570656633 hasConceptScore W1570656633C86803240 @default.
• W1570656633 hasLocation W15706566331 @default.
• W1570656633 hasLocation W15706566332 @default.
• W1570656633 hasLocation W15706566333 @default.
• W1570656633 hasLocation W15706566334 @default.
• W1570656633 hasOpenAccess W1570656633 @default.
• W1570656633 hasPrimaryLocation W15706566331 @default.
• W1570656633 hasRelatedWork W1990923693 @default.
• W1570656633 hasRelatedWork W2013625259 @default.
• W1570656633 hasRelatedWork W2028740321 @default.
• W1570656633 hasRelatedWork W2032948236 @default.
• W1570656633 hasRelatedWork W2062402161 @default.
• W1570656633 hasRelatedWork W2124966943 @default.
• W1570656633 hasRelatedWork W2134792106 @default.
• W1570656633 hasRelatedWork W2216929617 @default.
• W1570656633 hasRelatedWork W2224899546 @default.
• W1570656633 hasRelatedWork W2318003342 @default.
• W1570656633 hasRelatedWork W2321760681 @default.
• W1570656633 hasRelatedWork W2329189953 @default.
• W1570656633 hasRelatedWork W2397241885 @default.
• W1570656633 hasRelatedWork W2443143122 @default.
• W1570656633 hasRelatedWork W2600485710 @default.
• W1570656633 hasRelatedWork W2739605790 @default.
• W1570656633 hasRelatedWork W303293683 @default.
• W1570656633 hasRelatedWork W3042654301 @default.
• W1570656633 hasRelatedWork W46473342 @default.
• W1570656633 hasRelatedWork W2117169525 @default.
• W1570656633 hasVolume "2015" @default.
• W1570656633 isParatext "false" @default.
• W1570656633 isRetracted "false" @default.
• W1570656633 magId "1570656633" @default.
• W1570656633 workType "article" @default.